Medicines for Europe welcomes the publication of the ‘Joint Report on Health Care and Long-Term Care Systems & Fiscal Sustainability’, prepared by the European Commission’s Directorate-General f

Generic medicines save European countries 100 billion euros per year

Hardly 2017 will be the revolutionary year for Sopharma, but this may happen in 2018 – on original, Bulgarian molecule from Sopharma will be released on the global market. This is what we are working for and what would entirely change the image of our company. Everything else is an extensive development. This was said by Ognian Donev, the CEO of Sopharma, in an interview for Investor.bg, broadcasted on Bloomberg TV Bulgaria.

Twice as many patients treated in Europe because of generic medicine

“Medicines for Europe” strongly supports the French government campaign to boost generic medicines. Thanks to generic medicines, in Europe twice as many patients in 7 key therapeutic areas [1] (diabetes, depression, epilepsy, cardiovascular disease, hypertension, asthma/COPD, gastro-intestinal disease) have been able to be treated over the last ten years with no impact on overall treatment costs.

On the 30^th September “Zdravi” joined again the global initiative PARK(ing) Day. Parts of the parking spaces in Sofia were transformed into public spaces for people. Everyone had the chance to take part in writing “Life is good when we are healthy” by taking a photo with a letter of their liking and participating in the game of the application. As host #Zdravi usually challenges its visitors to do something good for themselves – to work out there, to test their minds or to stay hydrated with water and tea.